Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats
Abstract Mesenchymal stromal cells (MSC) have been demonstrated to attenuate renal ischemia/reperfusion (I/R) damage in rodent models. The mechanisms of such nephro-protection remain largely unknown. Furthermore, the optimal timing of MSC administration has been poorly investigated. Here, we compare...
| Glavni autori: | , , , , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
Nature Portfolio
2017-08-01
|
| Serija: | Scientific Reports |
| Online pristup: | https://doi.org/10.1038/s41598-017-08726-z |